[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YANAGIHARA et al., 1989 - Google Patents

Immunopharmacological studies on TBX, a new antiallergic drug (3) Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea …

YANAGIHARA et al., 1989

View PDF
Document ID
15601455742660118477
Author
YANAGIHARA Y
KASAI H
MATSUI S
NINOMIYA K
Publication year
Publication venue
The Japanese Journal of Pharmacology

External Links

Snippet

Materials and Methods Animals: Male Hartley guinea pigs weigh ing 300 to 450 g were obtained from Shizuoka Laboratory Animal Center. Chemicals: The chemicals used were TBX (Tokyo Tanabe), DSCG (Fujisawa), tranilast (Kissei), pyrilamine maleate (Sigma), pro …
Continue reading at www.jstage.jst.go.jp (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/826Asthma

Similar Documents

Publication Publication Date Title
Lorenz et al. Histamine release in man by propanidid and thiopentone: pharmacological effects and clinical consequences
Edwards et al. The chromones: history, chemistry and clinical development. A tribute to the work of Dr REC Altounyan
Saijo et al. Mechanism of the action of amoxanox (AA-673), an orally active antiallergic agent
Cox et al. Nature and modes of action of disodium cromoglycate (Lomudal®)
Patterson et al. Reagin-mediated asthma in rhesus monkeys and relation to bronchial cell histamine release and airway reactivity to carbocholine.
YANAGIHARA et al. Immunopharmacological studies on TBX, a new antiallergic drug (3) Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs
Anderson et al. Effect of a meal on human whole blood serotonin
Schulert et al. The physiologic disposition of phenylindanedione in man
Patterson et al. Comparative studies of two models of allergic respiratory disease
Michoud et al. Airway sensitivity to slow-reacting substance of anaphylaxis, histamine, and antigen in Ascaris sensitive monkeys
Richards et al. Ascaris-induced bronchoconstriction in primates experimentally infected with Ascaris suum ova.
WO2000071111A1 (en) Stimulating transport of glucose into animal tissue by the administration of pinitol
Grieco Double blind crossover study of cromolyn sodium inhibition of aerosol antigen challenge
Till Renal excretion of pseudoephedrine in the rat
Trembath et al. Potentiation of isoprenaline‐induced plasma cyclic AMP response by aminophylline in normal and asthmatic subjects.
Osborne et al. Hypotonic and isotonic aerosols increase bronchial reactivity in Basenji-Greyhound dogs
Nambu et al. OKY-046 inhibits anaphylactic bronchoconstriction and reduces histamine level in bronchoalveolar lavage fluid in sensitized guinea pigs
Pitt et al. Influence of the lung on arterial levels of endogenous prostaglandins E and F
Pauwels et al. The inhibition of allergen induced bronchospasm in man by oral BRL 10833
Sorkness et al. Anesthetic effects on pulmonary allergic responses in rats: changes in sensitivity to serotonin
Zimmermann et al. The Side of Action of Bronchodilating Drugs (β 2-Stimulators) on Antigen-Induced Bronchoconstriction
Dawson et al. The pharmacology of isamoxole [2-methyl-n-butyl-n (4-methyloxazol-2-yl) propanamide] LRCL 3950, a new anti-allergic compound.
Grieco Current concepts of the pathogenesis and management of asthma.
Axelrod et al. Physiological Disposition of 2-Phenyl Quinoline-4-Carboxylic Acid (Ginchophen) in Man. Method for its Estimation in Biological Material
Frey et al. Antagonism of arachidonic acid-induced bronchoconstriction in cats by aspirin-like analgesics